Kudarat, Uting Y.

HRN: 14-80-62  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/19/2024
CEFTAZIDIME 1GM (VIAL)
02/19/2024
02/26/2024
IV
1g
Every 8 Hours
DM Foot
Waiting Final Action 
02/19/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/19/2024
02/26/2024
IV
600mg
Every 8 Hours
DM Foot
Waiting Final Action 
02/28/2024
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
02/28/2024
02/28/2024
TOPICAL
Apply To Affected Areas
Once Daily
Empiric
Waiting Final Action 
03/04/2024
CO-AMOXICLAV 625MG (TAB)
03/04/2024
03/11/2024
PO
625
BiD
DM FOOT
Waiting Final Action 
03/04/2024
CLINDAMYCIN 300MG (CAP)
03/04/2024
03/11/2024
PO
300
Tid
Dm Foot
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: